Comparison of Relative Bioavailability of TIVICAY Neonatal Liquid Formulations to Pediatric Dispersible Tablets

Conference Reports for NATAP

20th International Workshop
on Clinical Pharmacology of HIV
Hepatitis & Other Antiviral Drugs
May 14-16, 2019. Noordwijk, the Netherlands


Comparison of Relative Bioavailability of TIVICAY Neonatal Liquid Formulations to Pediatric Dispersible Tablets

	1GlaxoSmithKline, Collegeville, PA, USA; 2GlaxoSmithKline, Stockley Park, UK; 3GlaxoSmithKline, Ware, Hertfordshire, UK; 4ViiV Healthcare, RTP, NC, USA; 5ViiV Healthcare, Nyon, Switzerland Correspondence to Rajendra Singh: rajendra.8.singh@gsk.com